Relmada Therapeutics Inc

RLMD

Add to Watchlist

5.310USD

0.0000.00%

Close 07-31 16:00（ET）Quotes delayed by 15 min

556.97MMarket Cap

LossP/E TTM

Relmada Therapeutics Inc

5.310

0.0000.00%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Relmada Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-07-31

Previous score

6.72

Change

1.42

The current valuation score of Relmada Therapeutics Inc is 8.14, ranking 124 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.84, which is -98.01% below the recent high of -0.10 and -41.06% above the recent low of -6.83.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.